- This event has passed.
Payment Reform Pathways for Antimicrobial Drugs: Duke-Margolis Center for Health Policy Roundtable Meeting
August 9, 2018 @ 8:30 am - 12:30 pm
Facilitating Payment Reform Pathways for Antimicrobial Drugs through FDA and CMS Collaboration
As you know, the rise in antimicrobial resistant infections is a major public health threat. Few treatment options are available and the pipeline of drug candidates is extremely limited. To help address this issue, Duke-Margolis has been focused on policy initiatives that could encourage development of antimicrobial products through post-market incentives.
Participants include Kevin Outterson, Executive Director of CARB-X